Designing a potent L1 protein-based HPV peptide vaccine: A bioinformatics approach.

Zahra Yazdani, Alireza Rafiei, Reza Valadan, Hossein Ashrafi, MarziehSharifi Pasandi, Mostafa Kardan

Computational biology and chemistry 2020 Apr

filter terms:

Oncogenic human papilloma viruses (HPV) are the cause of various types of cancer, specifically cervical cancer. L1 protein is the main protein of HPV capsid which targeted in many vaccine-producing attempts. However, they have not enough coverage on the various high risk HPV types. Therefore, having a low cost potent HPV vaccine to protect against all members of the α-papillomaviridea family will be promising. In this study, L1 protein-based peptide vaccine was designed using immunoinformatics methods which provides physicochemical properties such as stability in room temperature, potential of antigenicity, non-allergic properties and no requirement with eukaryotic host system. The designed vaccine has two HPV conserved epitopes with lengths 18 and 27 amino acids in all members of α-papillomaviridea. These peptides promote humoral and cellular immunity and INF-γ responses. In order to ensure strong induction of immune responses, Flagellin, a Toll like receptor 5(TLR-5) agonist, and a short synthetic toll like receptor 4 (TLR-4) agonist were also joined to the epitopes. Structure of the designed- vaccine was validated using Rampage and ERRAT and a high quality 3D structure of the vaccine protein was provided. Docking studies demonstrated an appropriate and stable interaction between the vaccine and TLR-5. The vaccine is expected to have a high quality structure and suitable properties including high stability, solubility and a high potential to be expressed in E.coli. High potentiality of the vaccine in inducing humoral and cellular immune responses, may be considered as an anti-tumor vaccine. Copyright © 2020 Elsevier Ltd. All rights reserved.

Citation

Zahra Yazdani, Alireza Rafiei, Reza Valadan, Hossein Ashrafi, MarziehSharifi Pasandi, Mostafa Kardan. Designing a potent L1 protein-based HPV peptide vaccine: A bioinformatics approach. Computational biology and chemistry. 2020 Apr;85:107209